This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Compugen Ltd., a drug discovery company, engages in the research, development, and commercialization of therapeutic and product candidates primarily in the United States, Europe, and Israel.View CGEN key stats
Compugen Ltd - CGEN - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Compugen Ltd as a
Sell with a ratings score of D.
Report Snippet: We rate COMPUGEN LTD (CGEN) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.